| Ytd | -61.52% | |
| 1y | -72.06% |
| Open | 1.53 | Prev Close | 1.56 | Low | 1.52 | High | 1.54 | Mkt Cap | 3.67M |
| Vol | 4.41K | Avg Vol | 102.99K | EPS | -1.49 | P/E | -1.02 | Forward P/E | N/A |
| Beta | 1.87 | Short Ratio | 2.21 | Inst. Own | 0.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.91 | 200-d Avg | 2.86 | 1yr Est | 0.00 |
KUALA LUMPUR, Malaysia, July 28, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) ("B
Gainers C3is (NASDAQ:CISS) shares moved upwards by 83.9% to $0.19 during Tuesday's pre-market s
Gainers Eos Energy Enterprises, Inc. - Right (NASDAQ:EOSER) stock increased by 74.7% to $0.05 durin
KUALA LUMPUR, Malaysia, May 29, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“Bi
KUALA LUMPUR, Malaysia, March 11, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) to
Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluat
BioNexus Gene Lab (NASDAQ: BGLC - Get Free Report) and Beauty Health (NASDAQ: SKIN - Get Free Report
BioNexus Gene Lab Corp. (NASDAQ: BGLC - Get Free Report) was up 1.7% during trading on Friday. The s
KUALA LUMPUR, Malaysia, Jan. 28, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“B
KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) ("B
SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC” or the “Company”),
KUALA LUMPUR, Malaysia and SINGAPORE, Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BG
KUALA LUMPUR, Malaysia and SINGAPORE, Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BG
KUALA LUMPUR, Malaysia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“B
BioNexus Gene Lab (NASDAQ: BGLC - Get Free Report) and PACS Group (NYSE: PACS - Get Free Report) are
Collaboration Expected to Advance FS2 Topical Platform and Strengthen BGLC's Biotech Footprint in As
KUALA LUMPUR, Malaysia, July 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC”, Nasdaq: B
Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading
KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC), a